ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2.

Vijayakumar Jawalagatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.